biotech is pretty interesting read our research @ demandrew.com

Canada
Pinned Tweet
consumer biotech is one of the biggest growth catalysts for life sciences, some thoughts demandrew.com/p/thesis-consu…
6
3
29
4,156
narratives in art markets
62
art markets
1
48
technological imagination
1
65
consumer biotech is one of the biggest growth catalysts for life sciences, some thoughts demandrew.com/p/thesis-consu…
6
3
29
4,156
special thanks to @jrkelly @EvanZhao6 @J_Sherz @HugoAmsellem @SofiasBio for the thoughts during the research process, opinions and mistakes are my own
3
194
i have no horse in the chinese biotech debate but it is interesting that the respective indexes are moving in different directions
1
49
chat is this chatgpt?
2
83
3 years ago... how we feeling about proteomics?
2
60
underrated point of the ajax story is that schrodinger owned a sizable equity stake - as with structure therapeutics (3.2B), Morphic (acquired 3.2B), among others... If they were a VC fund they would be taking victory laps, unfortunately they're a SaaS business...
Eli Lilly continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer portfolio. on.wsj.com/4vSypnF
2
143
Biotech funding (US/China/Global)
67
China biotech funding
52
Testing a longer-form research format away from the usual slide decks on bio-data for model training. Putting some highlights in the thread. demandrew.com/publish/post/1…
1
207
8/ Scaling generative models drives the cost of hypothesis generation to zero. However, the key is still wet lab validation. The gap between hypothesis generation and wet lab validation creates "speculation debt" that still needs to be bridged
1
31
TL;DR AI performance is tied to scaling laws, which means more data going in, hence, "data problems". The next wave of value creation will be tied to new sources of data that explore new biological space. But the issue is that this data isn't readily available for the industry.
28